Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapy

Annals of Surgery

Volumn 233, Issue 5, 2001, Pages 603-611

  Tirone, Thomas A ^a   Fagan, Shawn P ^a   Templeton, Nancy S ^a   Wang, Xaioping ^a   Brunicardi, F Charles ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLUCOSE; INSULIN; LIPOSOME; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; THYMIDINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER SURVIVAL; CELL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DEATH; ELECTROPHORETIC MOBILITY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUICIDE GENE; TREATMENT OUTCOME;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; INSULINOMA; LAC OPERON; MICE; MICE, INBRED ICR; MICE, SCID; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035038843     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200105000-00002     Document Type: Conference Paper

References (22)

1. Endocrine tumors of the pancreas: An update
2. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse
3. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene
4. Improved DNA: Liposome complexes for increased systemic delivery and gene expression
5. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo
6. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo
7. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
8. Use of tissue-specific promoter for targeted expression of the herpes simplex virus thymidine kinase gene in cervical carcinoma cells
9. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenoviurs
10. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene
11. Hekokinase type II: A novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells
12. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer
13. Inhibition of melanoma growth by adenoviral mediated HSV thymidine kinase gene transfer in vivo
14. Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: An effective in vitro drug-sensitization system
15. Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostrate cancer models
16. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
17. In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration
18. Adenovirus-mediated thymidine kinase gene transduction of human epithelial ovarian cancer cell lines followed by exposure to ganciclovir
19. Antiviral activity and mechanism of action of ganciclovir
20. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
21. The β-cell transcription factors and development of the pancreas
22. Protection of NIT-1 pancreatic β-cells from immune attack by inhibition of NF-κβ